alphaveSUPRIYA₹919.40

Supriya Lifescience Ltd.

₹ CrorePeersSTAR SPARC THYROCARE SHILPAMED VIYASH RUBICON YATHARTH PARKHOSPS

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	255.1	303.7	446.8	446.8
+ Capital Work-in-Progress	67.6	148.8	148.0	148.0
+ Other Intangibles	1.1	1.7	1.4	1.4
+ Non-current Investments	25.3	63.8	63.2	63.2
+ Other Non-current Assets	0.9	0.7	11.2	11.2
Total Non-current Assets	355.4	523.4	675.3	675.3
Current Assets
+ Inventories	115.8	85.2	118.3	118.3
+ Trade Receivables	84.7	111.7	134.4	134.4
+ Cash & Cash Equivalents	85.3	68.3	76.1	76.1
+ Other Bank Balances	72.3	6.6	3.1	3.1
+ Short-term Loans	0.5	0.7	0.9	0.9
+ Other Current Financial Assets	6.4	4.5	0.7	0.7
Current Financial Assets	249.2	191.8	215.2	215.2
+ Other Current Assets	99.9	120.7	103.5	103.5
Total Current Assets	464.9	397.8	437.0	437.0
Total Assets	820.3	921.2	1,112.3	1,112.3
Equity
+ Equity Share Capital	16.1	16.1	16.1	16.1
+ Other Equity / Reserves	683.4	799.3	980.7	980.7
Equity — Owners of Parent	699.5	815.4	996.8	996.8
Total Equity	699.5	815.4	996.8	996.8
Liabilities
+ Provisions — Non-current	5.9	0.8	1.3	1.3
+ Deferred Tax Liabilities	13.7	23.2	27.0	27.0
Non-current Liabilities	25.0	29.0	33.4	33.4
+ Borrowings — Current	16.6	0.0	0.0	0.0
+ Trade Payables	64.2	59.6	74.5	74.5
+ Other Current Financial Liab	0.8	1.6	1.8	1.8
Current Financial Liabilities	81.7	61.1	76.3	76.3
+ Provisions — Current	0.8	0.4	1.2	1.2
+ Other Current Liabilities	12.9	14.9	4.3	4.3
Current Liabilities	95.8	76.9	82.2	82.2
Total Liabilities	120.8	105.9	115.6	115.6
Total Equity & Liabilities	820.3	921.2	1,112.3	1,112.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 89%.